Press Release

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Sickle Cell Disease Treatment Market to Grow at a CAGR of 16.9% During 2021-2026, Aided by the Rising Prevalence of Haemoglobin Diseases Worldwide

According to a new report by EMR titled, ‘Global Sickle Cell Disease Treatment Market Report and Forecast 2021-2026’, the market reached a value of around USD 3.4 billion in 2020. It is expected to witness a healthy growth in the forecast period, growing at a CAGR of 16.9% between 2021 and 2026 to attain USD 8.50 billion by 2026.

The global sickle cell disease treatment industry is being driven by the heightened prevalence of haemoglobin diseases worldwide. As a result, increased demand for diagnosis, treatment, and prevention of haemoglobin diseases can be observed. Moreover, governments are increasingly collaborating with international organisations to raise awareness about diseases such as sickle cell diseases and organising blood donation drives among the masses while also ensuring the supply of required medicines in the adversely affected areas such as in the African region.

The rising emphasis of the leading market players in the healthcare industry to develop improved solutions for sickle cell disease treatment is expected to positively impact the industry growth. For instance, in June 2021, Global Blood Therapeutics, Inc. (NASDAQ: GBT) announced the Promising Innovative Medicine (PIM) designation assigned to their Voxelotor by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom for the potential treatment of hemolytic anaemia in adult and patients of 12 years of age with sickle cell disease (SCD). In addition, a leading gene therapy vendor, bluebird bio, Inc. (NASDAQ: BLUE), in a press release dated June 2021, announced the lifting of the FDA clinical hold on sickle cell disease and β-Thalassemia studies of LentiGlobin gene therapy, which is being tested as a one time therapy for SCD and betibeglogene autotemcel gene therapy, further helping reduce the need for blood transfusions. Such developments are expected to significantly impact the growth of the sickle cell disease treatment industry in the forecast period.

Market Breakup by Treatment and Region:

  • The market is divided based on treatment into blood transfusion, pharmacotherapy, and bone marrow transplant.
  • Region-wise, the global market for sickle cell disease treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The global market for sickle cell disease treatment is being driven by the rapid increase in the incidences of haemoglobin diseases worldwide.  
  • The rapid investments in the healthcare infrastructure are expected to significantly contribute to the market expansion. 
  • The increased technological advancements are also aiding the industry growth. 
  • The growing initiatives by international organisations to create awareness about sickle cell disease are further propelling the market growth.

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for sickle cell disease treatment for the periods (2016-2020) and (2021-2026). 
  • The report also offers historical (2016-2020) and forecast (2021-2026) market information for the treatments and regions of sickle cell disease treatment.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global sickle cell disease treatment market are Emmaus Life Sciences, Inc., Global Blood Therapeutics, Inc., bluebird bio, Inc., Pfizer Inc., Novartis International AG, and others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER